Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. (SHE:301617)
China flag China · Delayed Price · Currency is CNY
44.87
-0.06 (-0.13%)
At close: Nov 13, 2026

SHE:301617 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
172.22172.29212.84182.1176.32103.29
Depreciation & Amortization
33.8333.8329.2825.1122.2719.71
Other Amortization
0.890.89--0.610.17
Loss (Gain) From Sale of Assets
-0.1-0.10.03--0.34-
Asset Writedown & Restructuring Costs
3.473.47-4.517.363.66
Loss (Gain) From Sale of Investments
-6.52-6.52--1.41.851.4
Provision & Write-off of Bad Debts
2.82.81.56---
Other Operating Activities
121.373.030.01-0.060.222.05
Change in Accounts Receivable
-78.24-78.24-51.43-83.26-64.99-42.21
Change in Inventory
-112-112-39.27-34.46-36.26-27.5
Change in Accounts Payable
-22.7-22.78.7255.0180.6519.37
Change in Other Net Operating Assets
0.690.690.04-1.010.91-0.39
Operating Cash Flow
115.3-2.97161.76146.23188.9579.51
Operating Cash Flow Growth
1247.76%-10.62%-22.61%137.64%62.36%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-100.72-85.1-55.45-66.98-135.05-67.93
Sale of Property, Plant & Equipment
0.510.240.09-0.640.06
Cash Acquisitions
-12.5-12.5----
Investment in Securities
230-410-69.15-45.63-18.52
Other Investing Activities
6.764.95-1.40.618.23
Investing Cash Flow
124.04-502.41-55.363.58-179.42-78.17

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-0.56-0.7771.5266.82
Total Debt Issued
3.120.56-0.7771.5266.82
Short-Term Debt Repaid
----0.05-70.52-91.14
Long-Term Debt Repaid
--0.28-0.28-1.59-1.18-0.47
Lease Payments
-0.28-0.28-0.28-1.59-1.18-0.47
Total Debt Repaid
-0.84-0.28-0.28-1.64-71.69-91.61
Net Debt Issued (Repaid)
2.270.28-0.28-0.87-0.18-24.79
Issuance of Common Stock
--663.46--50.43
Common Dividends Paid
-44.12-88.42----1.96
Other Financing Activities
12.34-5.26-37.08-2.41-0.46-
Financing Cash Flow
-29.51-93.4626.09-3.28-0.6423.68

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.67-0.7-1.180.110.35-0.02
Net Cash Flow
210.51-599.47731.32146.649.2525.01

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
14.58-88.07106.3179.2653.911.58
Free Cash Flow Growth
--34.14%47.04%365.44%4.51%
Free Cash Flow Margin
0.94%-6.01%8.01%7.73%6.75%2.21%
Free Cash Flow Per Share
0.08-0.511.060.610.410.09
Levered Free Cash Flow
-114.87-216.2684.3226.962.018.89
Unlevered Free Cash Flow
-114.83-216.2284.4926.962.310.12
Free Cash Flow After Leases
14.3-88.35106.0377.6752.7211.11

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
---00.46-
Cash Income Tax Paid
52.1247.1266.7457.0252.7928.21
Change in Working Capital
-212.66-212.66-81.95-64.03-19.34-50.76